Qyuns Therapeutics Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-421.8	-507.75	-298.19	-411.04
Depreciation & Amortization	32.6	32.29	30.54	25.64
Loss (Gain) From Sale of Assets	0.01	0.01	-	0.01
Loss (Gain) From Sale of Investments	-5.7	-5.7	-11.9	233.6
Stock-Based Compensation	131.3	131.3	41.56	11.73
Other Operating Activities	14.47	-0.8	-14.08	-2.09
Change in Inventory	-4.94	-4.94	-	-
Change in Accounts Payable	72.1	72.1	12.81	17.38
Change in Unearned Revenue	0.23	0.23	-0.64	-0.59
Change in Other Net Operating Assets	-17.41	-17.41	14.69	2.77
Operating Cash Flow	-199.16	-300.68	-225.21	-122.58
Capital Expenditures	-3.84	-7.87	-20.11	-57.98
Sale (Purchase) of Intangibles	-0.26	-0.07	-2.65	-0.96
Investment in Securities	94.6	246.39	13.18	-195.54
Other Investing Activities	4.36	4.67	3.88	7.06
Investing Cash Flow	94.87	243.11	-5.7	-247.42
Long-Term Debt Issued	-	113.6	15.9	-
Long-Term Debt Repaid	-	-66.65	-16.55	-3.01
Net Debt Issued (Repaid)	220.01	46.95	-0.65	-3.01
Issuance of Common Stock	196.54	29.5	228	300.07
Other Financing Activities	-37.25	-15.24	-15.85	-15.59
Financing Cash Flow	379.3	61.21	211.49	281.48
Foreign Exchange Rate Adjustments	0.57	-0.43	14.46	-2.72
Net Cash Flow	275.58	3.21	-4.97	-91.23
Free Cash Flow	-202.99	-308.56	-245.33	-180.55
Free Cash Flow Margin	-340.19%	-2091.76%	-2539.08%	-845.71%
Free Cash Flow Per Share	-0.95	-1.50	-1.38	-1.55
Cash Interest Paid	15.58	14.42	15.49	15.33
Levered Free Cash Flow	-	-125.29	-152.54	-
Unlevered Free Cash Flow	-	-114.77	-140.86	-
Change in Net Working Capital	-	-51	-12.41	-

Source: S&P Capital IQ. Standard template. Financial Sources.